Top Markets
Coin of the day
Thalia Therapeutics Plc Thalia Therapeutics Plc

Thalia Therapeutics Plc

THAT
Kedudukan dalam Saham #40845
Thalia Therapeutics Plc, a specialized pharmaceutical company established in... Thalia Therapeutics Plc, a specialized pharmaceutical company established in 1979 and headquartered in Chellaston, UK, focuses on developing advanced nanoparticle silica delivery systems. These innovative systems are designed to enhance the cellular uptake and effectiveness of various cancer treatments and vaccines. The company's product portfolio includes Nuvec, a unique silica nanoparticle delivery platform distinguished by its irregular surface structure that effectively encapsulates and safeguards genetic material such as siRNA, RNA, and DNA. Additionally, it offers Liptide, a specialized platform engineered for the targeted delivery of a proprietary siRNA sequence to silence fibrotic genes. Thalia Therapeutics is also advancing N4 101, an orally administered inflammation inhibitor currently undergoing pre-clinical evaluation for the treatment of inflammatory bowel disease, alongside ECP105, which is being developed to prevent ocular scarring. The firm, previously known as N4 Pharma Plc, officially rebranded to Thalia Therapeutics Plc in March 2026.
Harga Saham
$0.00884456
Modal Pasaran
$73.61K
Perubahan (1 hari)
-3.70%
Perubahan (1 tahun)
32.93%
Negara
GB
Perdagangan Thalia Therapeutics Plc (THAT)

Kategori

Sejarah pecahan saham untuk Thalia Therapeutics Plc (THAT)
Saham Thalia Therapeutics Plc (simbol: THAT) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 13, 2026.
Satu saham THAT yang dibeli sebelum Aug 13, 2026 kini bersamaan dengan 0 saham THAT.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE